RespireRx Pharmaceuticals Market Cap

RespireRx Pharmaceuticals has a market cap or net worth of $2.18 million as of April 4, 2025. Its market cap has increased by 398.01% in one year.

Market Cap

2.18M

Enterprise Value

5.77M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 1, 1992, RespireRx Pharmaceuticals's market cap has decreased from 26.39M to 2.18M, a decrease of -91.72%. That is a compound annual growth rate of -7.29%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2025	2.18M	187.50%
Dec 31, 2024	759.57K	65.58%
Dec 29, 2023	458.74K	58.87%
Dec 30, 2022	288.75K	-74.38%
Dec 31, 2021	1.13M	-45.46%
Dec 31, 2020	2.07M	411.01%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.83B
Endo Inc.	1.79B
Nika Pharmaceuticals	1.02B
Veradigm	729.19M
Elite Pharmaceuticals	387.78M
Glass House Brands	354.11M
Northwest Biotherapeutics	284.87M
CytoDyn	282.34M

Market Cap Rankings